Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs114817817
rs114817817
Entrez Id: 57522;105369798
Gene Symbol: SRGAP1;LOC105369798
SRGAP1;LOC105369798
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
0.800 GeneticVariation UNIPROT SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility. 23539728 2013
dbSNP: rs781626187
rs781626187
Entrez Id: 57522;105369801
Gene Symbol: SRGAP1;LOC105369801
SRGAP1;LOC105369801
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
0.800 GeneticVariation UNIPROT SRGAP1 is a candidate gene for papillary thyroid carcinoma susceptibility. 23539728 2013
dbSNP: rs114817817
rs114817817
Entrez Id: 57522;105369798
Gene Symbol: SRGAP1;LOC105369798
SRGAP1;LOC105369798
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
T 0.800 SusceptibilityMutation CLINVAR
dbSNP: rs781626187
rs781626187
Entrez Id: 57522;105369801
Gene Symbol: SRGAP1;LOC105369801
SRGAP1;LOC105369801
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
C 0.800 CausalMutation CLINVAR
dbSNP: rs797044990
rs797044990
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
0.800 GeneticVariation UNIPROT
dbSNP: rs797044990
rs797044990
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
A 0.800 CausalMutation CLINVAR
dbSNP: rs11175194
rs11175194
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C0677886
Disease:
Epithelial ovarian cancer
G 0.710 GeneticVariation GWASCAT Finally, we identify two EOC susceptibility loci at 9q22.33 (rs1413299 in COL15A1, P(meta) = 1.88 × 10(-8)) and 10p11.21 (rs1192691 near ANKRD30A, P(meta) = 2.62 × 10(-8)), and two consistently replicated loci at 12q14.2 (rs11175194 in SRGAP1, P(meta) = 1.14 × 10(-7)) and 9q34.2 (rs633862 near ABO and SURF6, P(meta) = 8.57 × 10(-7)) (P<0.05 in all three stages). 25134534 2014
dbSNP: rs11175194
rs11175194
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C0677886
Disease:
Epithelial ovarian cancer
0.710 GeneticVariation BEFREE Finally, we identify two EOC susceptibility loci at 9q22.33 (rs1413299 in COL15A1, P(meta) = 1.88 × 10(-8)) and 10p11.21 (rs1192691 near ANKRD30A, P(meta) = 2.62 × 10(-8)), and two consistently replicated loci at 12q14.2 (rs11175194 in SRGAP1, P(meta) = 1.14 × 10(-7)) and 9q34.2 (rs633862 near ABO and SURF6, P(meta) = 8.57 × 10(-7)) (P<0.05 in all three stages). 25134534 2014
dbSNP: rs789709
rs789709
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C0005890
Disease:
Body Height
0.700 GeneticVariation GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
dbSNP: rs6581526
rs6581526
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C0410702
Disease:
Adolescent idiopathic scoliosis
0.700 GeneticVariation GWASCAT The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease. 30019117 2018
dbSNP: rs6581526
rs6581526
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C1837461
Disease:
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
0.700 GeneticVariation GWASCAT The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease. 30019117 2018
dbSNP: rs7131691
rs7131691
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C0596887
Disease:
mathematical ability
A 0.700 GeneticVariation GWASCAT Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. 30038396 2018
dbSNP: rs61754221
rs61754221
Entrez Id: 57522;105369798
Gene Symbol: SRGAP1;LOC105369798
SRGAP1;LOC105369798
CUI: C4225426
Disease:
THYROID CANCER, NONMEDULLARY, 2
0.700 GeneticVariation UNIPROT
dbSNP: rs11175194
rs11175194
Entrez Id: 57522
Gene Symbol: SRGAP1
SRGAP1
CUI: C4721610
Disease:
Carcinoma, Ovarian Epithelial
0.010 GeneticVariation BEFREE Finally, we identify two EOC susceptibility loci at 9q22.33 (rs1413299 in COL15A1, P(meta) = 1.88 × 10(-8)) and 10p11.21 (rs1192691 near ANKRD30A, P(meta) = 2.62 × 10(-8)), and two consistently replicated loci at 12q14.2 (rs11175194 in SRGAP1, P(meta) = 1.14 × 10(-7)) and 9q34.2 (rs633862 near ABO and SURF6, P(meta) = 8.57 × 10(-7)) (P<0.05 in all three stages). 25134534 2014